Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
INTELLIGENT BIO SOLUTIONS INC. (GBS)
|
Add to portfolio |
|
|
|
| Price: |
$1.64
| | Metrics |
| OS: |
2.33
|
M
| |
-288
|
% ROE
|
| Market cap: |
$3.82
|
M
| |
|
|
|
Net cash:
|
$781.2
|
k
| |
$0.34
|
per share
|
|
EV:
|
$3.04
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($7.6)
|
M
| |
|
|
|
EBIT
|
($8.4)
|
M
| |
|
|
| EPS |
($8.91)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 |
| Revenues | 1.3 | 9.2 | 2.0 | 0.2 |
| Revenue growth | -86.4% | 365.1% | 949.3% | |
| Cost of goods sold | 0.9 | 8.8 | 7.6 | 3.0 |
| Gross profit | 0.3 | 0.4 | -5.6 | -2.9 |
| Gross margin | 26.0% | 4.7% | -281.4% | -1513.7% |
| General and administrative | 8.0 | 4.9 | 3.4 | 2.3 |
| EBITA | -7.6 | -8.3 | -5.6 | -2.9 |
| EBITA margin | -603.5% | -90.5% | -281.4% | -1513.7% |
| Amortization of intangibles | 0.9 | | | |
| EBIT | -8.4 | -8.3 | -5.6 | -2.9 |
| EBIT margin | -671.2% | -90.5% | -281.4% | -1513.7% |
| Pre-tax income | -10.7 | -8.3 | -7.1 | -3.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.3% | 0.3% | 0.3% | 0.9% |
| Net income | -10.6 | -8.3 | -7.0 | -3.2 |
| Net margin | -845.9% | -90.2% | -355.3% | -1676.2% |
| |
| Diluted EPS | ($10.58) | ($11.33) | ($0.68) | ($0.37) |
| Shares outstanding (diluted) | 1.0 | 0.7 | 10.4 | 8.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|